Thank you Rich. Let me begin by providing a portfolio update. Overall, the credit fundamentals and financial performance of our portfolio of companies remains strong. As Michael mentioned, we continue to have no direct exposure to the energy sector. At June 30, our portfolio was 100% performing and we feel confident about our company's ability to continue to deleverage. On a weighted average basis and measured at fair value, our internal risk assessments remained at approximately 2, based on our 1-to-4 risk rating scale, with 1 representing the least amount of risk. At June 30, the weighted average yield on our portfolio was 7%, up from 6.9% at the end of the first quarter. While it is too early to confirm a trend, it does feel like yield compression has bottomed out. SUNS' portfolio ended Q2 with investments in 47 portfolio companies across 25 different industries. SUNS' average issuer exposure is just under $8 million when including our ownership position of loans held in FLLP. At June 30, our portfolio was invested roughly 99% in senior secured loans, including 80% in senior secured loans across 45 portfolio companies, 10% in Gemino Healthcare Finance, whose portfolio consists entirely of asset-backed senior secured loans and 8% in FLLP, whose portfolio also consists entirely of first lien senior secured loans. In addition, we have approximately 1% in unsecured loans and 0.1% in common equity, excluding Gemino and FLLP. Including our investment in Gemino and FLLP, 95% of our income producing portfolio was invested in floating-rate assets and 5.5% was invested in fixed rate when measured at fair value. During the second quarter, we had gross originations of just over $58 million of first lien senior secured floating-rate loans across nine different issuers. Of the total originations, $40 million of investments was directly on SUNS' balance sheet and $18 million was across five investments in the FLLP program. During that same period, gross loans repaid or sold totaled approximately $34 million. Before I give an overview of our Q2 activity, let me provide an update on our First Lien Loan Program as well as our strategic investment in Gemino Healthcare Finance. As a reminder, our strategic partnership with VOYA Investment Management to create the FLLP provides incremental long-term capital from a like-minded credit investor that expands our origination capacity and allows us to scale the SUNS balance sheet more effectively. At June 30, when measured at fair value, the FLLP had approximately $55 million of senior secured first lien floating-rate loans across 12 issuers with an average loan balance of just over $4.5 million. During the second quarter, FLLP invested approximately $18 million in senior secured loans across five portfolio companies while loan repayments were negligible. For the second quarter, FLLP paid distribution to SUNS equating approximately to a 6% yield on the cost of our investment. Portfolio growth will allow FLLP to more fully utilize its credit facility. When fully ramped, we expect our distribution yield from FLLP to be in the low teens. At June 30, FLLP had $22.5 million of borrowings outstanding under its $75 million revolving credit facility, equating to a debt to equity ratio of 0.6 times. We will upsize our credit facility there with an expected debt to equity ratio of up to 2 times as the portfolio ramps, driving further ROE. Now I will turn to Gemino. At quarter end, Gemino had $121 million of funded senior secured revolving or term loans across 36 issuers with an average loan balance of approximately $3.4 million. During Q2, Gemino had originations totaling just under $11 million and prepayments totaling just under $9 million. All of the loan commitments at Gemino are floating-rate, asset-based senior secured and cash pay, consistent with the first quarter. For Q2 Gemino, paid a distribution to SUNS equating to a 10.5% annualized yield, consistent with the distribution paid for Q1. We continue to believe that Gemino has upside potential to drive a higher return on equity over the second half of this year. In addition, Gemino had $90 million outstanding under its $110 million credit facility. Now let me highlight a couple of our Q2 investments. We invested $10 million in the first lien term loan of LegalZoom which is majority owned by Permira. LegalZoom is the leading provider of online legal services to small businesses and consumers in the U.S.. The $156 million unit tranche was underwritten by a small club of investors as attractive covenant package and call protection. Our all-in yield on this investment is just under 9% and total leverage is 4.2 times. SUNS also invested $6 million in the first lien term loan of Pet Supplies Plus which is the third largest specialty pet retailer in the U.S. backed by Irving Place Capital. The all senior first lien net leverage is 3.7 times and the all-in yield is approximately 6% on this investment. In addition, we invested $10 million in the $100 million first lien term loan issued by Salient Partners, a leading diversified asset manager with approximately $37 billion of AUM. First lien leverage to our tranche is 2.65 times and our all-in yield is approximately 8%. Finally, we funded $15 million in the first lien term loan of Pet Supermarket in support of Roark Capital's acquisition of the company. Pet Supermarket is one of the largest pet specialty retailers in the U.S.. The first lien tranche was just under $200 million, underwritten by small public investors and carries and all-in yield of just under 7%. I'll now highlight a couple of our repayments during Q2. Solar Senior was repaid at a premium to par on its second lien term loan investment in Ikaria in conjunction with Madison Dearborn's sale of the business. Our IRR was 10.8%. We were also repaid at a premium to par on our $5 million investment in IPC Systems' first lien term loan. The company conducted a repricing transaction that we elected to not participate in. We originally invested in Q1 2015 as part of Center Bridge's buyout of the company. Though short-lived, our IRR in this investment was just under 25%. SUNS has also repaid on our $8 million first lien investment in Genoa pursuant to the company's sale to Advent Partners. Solar Senior originally invested in Genoa in the second quarter of last year as part of Nautic's combination of this country's two largest mental health pharmacies. Our IRR on this investment is just over 6.25%. In addition, Solar was repaid at par on its $9 million investment in the first lien term loan of Pro Mach in connection with a repricing amendment which we declined to participate in. SUNS had originally invested in Pro Mach back in 2014 in connection with AEA's acquisition of the company. Our IRR on this investment was 7.5%. And lastly, we were repaid at a premium to par on our $4.5 million second lien investment in Blue Coat Systems. The IRR on this investment was just under 12%. Thus far in third quarter, we have visibility on only $10 million of repayments across the SUNS portfolio. We continue to source attractive investment opportunities and we're optimistic about our ability to generate incremental investment income at both FLLP and Gemino as we further deploy our available capital. Now I'll turn the call back to Michael.